New feature of modern basal insulin therapy in the treatment of patients with diabetes mellitus type 1 and type 2 from the results of clinical trials to real clinical practice

• Alexander S. Ametov
• Natalya A. Chernikova

AbstractIt should be emphasized that among the existing methods of treatment of diabetes mellitus insulin therapy is of particular importance. long duration type 2 diabetes with persistent hyperglycemia lead to decline products β-cell insulin, thus signaling the development of relative insulin deficiency. In type 1 diabetes on a background of absolute insulin defidency, insulin is the only possible method of treating this group of patients. Obtaining human insulin analog with modern genetic engineering techniques to improve the quality of diabetes management. Basal insulin analogs have a smoother profile, a longer duration of action than traditional basal insulins, proven efficacy and safety. The appearance of new basal insulin may improve existing therapy due to a prolonged and sustained action at one injection, comparable glycemic control, less risk of hypoglycemia and less weight gain.

Keywords:insulin, diabetes mellitus, clinical practice, basal insulin analogs, glargine U-100, glargine U-300, EDITION 1, 2, 3, 4

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)